oncology

Amgen unveils Partners of Choice oncology network
Amgen unveils Partners of Choice oncology network
Medical Marketing and Media
Amgen
expert panels
oncology
cancer
Flag link:
White House announces plan to tackle cancer drug supply issues
White House announces plan to tackle cancer drug supply issues
10news.com
cancer
oncology
drug shortages
Joe Biden
Flag link:
Immuneering takes aim at cancer’s ‘superhighway’
Immuneering takes aim at cancer’s ‘superhighway’
Pharma Voice
Immuneering
Neuroscience
cancer
oncology
RAS
Flag link:
Mariana Oncology Announces $175 Million Series B Financing
Mariana Oncology Announces $175 Million Series B Financing
BioSpace
Mariana Oncology
oncology
funding
Flag link:
Radiopharmaceuticals for cancer: Making radiation precise
Radiopharmaceuticals for cancer: Making radiation precise
BioPharma Dive
radiopharmaceuticals
cancer
oncology
Rayze Bio
ITM
Aktis Oncology
Abdera Therapeutics
Convergent Therapeutics
Precirix
Alpha-9 Theranostics
Mariana Oncology
Ariceum Therapeutics
Ratio Therapeutics
Radionetics Oncology
Artbio
Flag link:
Gilead inks $66M+ deal with Tentarix in oncology, inflammatory diseases
Gilead inks $66M+ deal with Tentarix in oncology, inflammatory diseases
Fierce Biotech
Tentarix Biotherapeutics
Gilead Sciences
oncology
inflammatory disease
Flag link:
US pharmacists say drug shortages are affecting cancer care
US pharmacists say drug shortages are affecting cancer care
Pharmaphorum
cancer
oncology
drug shortages
Flag link:
Daiichi Sankyo will remain 'dominant' in ADC market for oncology treatments
Daiichi Sankyo will remain 'dominant' in ADC market for oncology treatments
Biopharma Reporter
Daiichi Sankyo
antibody drug conjugate
oncology
Seagen
Roche
Flag link:
Amgen Clinches Clinical Wins in SCLC and Colorectal Cancer
Amgen Clinches Clinical Wins in SCLC and Colorectal Cancer
BioSpace
Amgen
oncology
colorectal cancer
small cell lung cancer
tarlatamab
Lumakras
Flag link:
Reed Jobs, son of Steve Jobs, takes the wraps off a $200 million venture fund that will back new cancer treatments
Reed Jobs, son of Steve Jobs, takes the wraps off a $200 million venture fund that will back new cancer treatments
TechCrunch
venture capital
Emerson Collective
oncology
Steve Jobs
Reed Jobs
Flag link:
Alkermes, nearing oncology split, posts big Q2 sales gain after winning J&J arbitration case
Alkermes, nearing oncology split, posts big Q2 sales gain after winning J&J arbitration case
Fierce Pharma
JNJ
Alkermes
oncology
earnings
Flag link:
In fast-growing KRAS field, this oncology veteran is chasing the toughest cancer targets
In fast-growing KRAS field, this oncology veteran is chasing the toughest cancer targets
Pharma Voice
Affini-T Therapeutics
oncology
KRAS inhibitors
Flag link:
Gilead drug acquired in $5B buyout fails key blood cancer trial
Gilead drug acquired in $5B buyout fails key blood cancer trial
BioPharma Dive
Gilead Sciences
M&A
oncology
clinical trials
magrolimab
MDS
Forty Seven
Flag link:
Keytruda Keeps Racking Up Approvals and Clinical Wins in ’23
Keytruda Keeps Racking Up Approvals and Clinical Wins in ’23
BioSpace
Merck
Keytruda
oncology
cancer
Flag link:
Intensity Therapeutics Prices Upsized 3.9M Share IPO at $5/sh
Intensity Therapeutics Prices Upsized 3.9M Share IPO at $5/sh
Investing.com
Intensity Therapeutics
oncology
cancer
IPOs
Flag link:
Lilly to Buy European ADC Player Emergence Therapeutics
Lilly to Buy European ADC Player Emergence Therapeutics
BioSpace
Eli Lilly
M&A
Emergence Therapeutics
antibody-drug conjugate
oncology
Flag link:
Artificial intelligence advances cancer diagnostics in the next decade
Artificial intelligence advances cancer diagnostics in the next decade
Clinical Trials Arena
diagnostics
Medtech
artificial intelligence
cancer
oncology
Mindpeak
Proscia
Flag link:
Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says
Bayer needs 'midsize acquisition' to reach $10B oncology sales goal, exec says
Fierce Pharma
Bayer
oncology
M&A
Flag link:
BIO: Jazz is auditioning new bandmates in an M&A market ripe with talent
BIO: Jazz is auditioning new bandmates in an M&A market ripe with talent
Fierce Biotech
Jazz Pharmaceuticals
Bruce Cozadd
M&A
BIO 2023
neurology
oncology
Flag link:
Acepodia Secures $100 Million Series D Financing to Advance
Acepodia Secures $100 Million Series D Financing to Advance
BioSpace
Acepodia
funding
oncology
gamma delta T cells
ACE1831
Flag link:

Pages